|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Marzo AM, DeWeese TL, Platz EA, et al:
Pathological and molecular mechanisms of prostate carcinogenesis:
implications for diagnosis, detection, prevention, and treatment. J
Cell Biochem. 91:459–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Isaacs WB, Bova GS, Morton RA, et al:
Molecular biology of prostate cancer progression. Cancer Surv.
23:19–32. 1995.PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rigoutsos I: New tricks for animal
microRNAS: targeting of amino acid coding regions at conserved and
nonconserved sites. Cancer Res. 69:3245–3248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirata H, Ueno K, Shahryari V, et al:
MicroRNA-182–5p promotes cell invasion and proliferation by down
regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
PLoS One. 8:e555022013. View Article : Google Scholar
|
|
9
|
Wang H, Lu YT, Luo L, et al: MicroRNA-195
inhibits the proliferation of human glioma cells by directly
targeting cyclin D1 and cyclin E1. PLoS One. 8:e549322013.
View Article : Google Scholar
|
|
10
|
Musiyenko A, Bitko V and Barik S: Ectopic
expression of miR-126*, an intronic product of the
vascular endothelial EGF-like 7 gene, regulates prostein
translation and invasiveness of prostate cancer LNCaP cells. J Mol
Med (Berl). 86:313–322. 2008. View Article : Google Scholar
|
|
11
|
Vrba L, Jensen TJ, Garbe JC, et al: Role
for DNA methylation in the regulation of miR-200c and miR-141
expression in normal and cancer cells. PLoS One. 5:e86972010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun TW, Wang C, Xing J and Wu D: miR-429
modulates the expression of c-myc in human gastric carcinoma cells.
Eur J Cancer. 47:2552–2559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han Y, Chen J, Zhao X, et al: MicroRNA
expression signatures of bladder cancer revealed by deep
sequencing. PLoS One. 6:e182862011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nam EJ, Yoon H, Kim SW, et al: MicroRNA
expression profiles in serous ovarian carcinoma. Clin Cancer Res.
14:2690–2695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Heneghan HM, Miller N and Kerin MJ: MiRNAs
as biomarkers and therapeutic targets in cancer. Curr Opin
Pharmacol. 10:543–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu W, Xu H, Zhu D, et al: miR-200bc/429
cluster modulates multidrug resistance of human cancer cell lines
by targeting BCL2 and XIAP. Cancer Chemother Pharmacol. 69:723–731.
2012. View Article : Google Scholar
|
|
19
|
Uhlmann S, Zhang JD, Schwäger A, et al:
miR-200bc/429 cluster targets PLCγ1 and differentially regulates
proliferation and EGF-driven invasion than miR-200a/141 in breast
cancer. Oncogene. 29:4297–4306. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JW, Park YA, Choi JJ, et al: The
expression of the miRNA-200 family in endometrial endometrioid
carcinoma. Gynecol Oncol. 120:56–62. 2011. View Article : Google Scholar
|
|
21
|
Wu Z, Sun H, Zeng W, et al: Upregulation
of MicroRNA-370 induces proliferation in human prostate cancer
cells by downregulating the transcription factor FOXO1. PLoS One.
7:e458252012. View Article : Google Scholar
|
|
22
|
Ishteiwy RA, Ward TM, Dykxhoorn DM and
Burnstein KL: The microRNA-23b/-27b cluster suppresses the
metastatic phenotype of castration-resistant prostate cancer cells.
PLoS One. 7:e521062012. View Article : Google Scholar
|
|
23
|
Davidovic L, Durand N, Khalfallah O, et
al: A novel role for the RNA-binding protein FXR1P in myoblasts
cell-cycle progression by modulating p21/Cdkn1a/Cip1/Waf1 mRNA
stability. PLoS Genet. 9:e10033672013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dai L, Liu YQ, Liu JY, et al: A novel
cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell
cycle progression and cell survival: implications in cancer
therapy. Cancer Lett. 333:103–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lacy ER, Wang Y, Post J, et al: Molecular
basis for the specificity of p27 toward cyclin-dependent kinases
that regulate cell division. J Mol Biol. 349:764–773. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Slingerland J and Pagano M: Regulation of
the cdk inhibitor p27 and its deregulation in cancer. J Cell
Physiol. 183:10–17. 2000. View Article : Google Scholar : PubMed/NCBI
|
